SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010507
Filing Date
2019-11-08
Accepted
2019-11-08 09:24:40
Documents
65
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gemp-20190930x10q.htm 10-Q 1654680
2 EX-31.1 gemp-20190930ex311f21471.htm EX-31.1 17963
3 EX-32.1 gemp-20190930ex32189ca64.htm EX-32.1 12149
  Complete submission text file 0001558370-19-010507.txt   5230834

Data Files

Seq Description Document Type Size
4 EX-101.INS gemp-20190930.xml EX-101.INS 839294
5 EX-101.SCH gemp-20190930.xsd EX-101.SCH 47043
6 EX-101.CAL gemp-20190930_cal.xml EX-101.CAL 29265
7 EX-101.DEF gemp-20190930_def.xml EX-101.DEF 160236
8 EX-101.LAB gemp-20190930_lab.xml EX-101.LAB 396212
9 EX-101.PRE gemp-20190930_pre.xml EX-101.PRE 298814
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 191202374
SIC: 2834 Pharmaceutical Preparations